Tadalafil Daily Used Post Turp
NCT06788704 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 270
Last updated 2025-01-28
Summary
to assess the effect of early tadalafil 5 mg once daily on persistent storage lower urinary tract symptoms (LUTS) and erectile function after transurethral resection of the prostate (TURP).
Conditions
- Erectile Dysfunction Following Urethral Surgery
Interventions
- DRUG
-
Tadalafil 5mg
Patient recive tadalafil 5mg once daily early post turp
- DRUG
-
Patient recive placebo once daily early post turp
Sponsors & Collaborators
-
Kafrelsheikh University
lead OTHER
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-01
- Primary Completion
- 2022-10-01
- Completion
- 2022-10-01
Countries
- Egypt
Study Locations
More Related Trials
-
A Study of Tadalafil in Men With Benign Prostatic Hyperplasia
NCT00970632 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Tadalafil After Radical Prostatectomy
NCT01026818 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy
NCT05537272 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms
NCT02252367 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Between Tamsulosin and Tadalafil in Management of Benign Prostatic Hyperplasia Long Term Study
NCT05818670 ·Status: COMPLETED ·Phase: PHASE4
-
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH
NCT05834270 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB
NCT05494567 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients
NCT03246880 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Benign Prostatic Hyperplasia
NCT01152190 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients
NCT05558007 ·Status: RECRUITING ·Phase: PHASE2
-
Comparative Study Between Rezum Therapy in Small and Large Prostates
NCT06818383 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction
NCT02862483 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers
NCT00848081 ·Status: COMPLETED ·Phase: PHASE3
-
Early Versus Late Catheter Removal in Patients With Acute Urinary Retention Secondary to BPH Under Tamsulosin Treatment
NCT03280420 ·Status: COMPLETED ·Phase: NA
-
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
NCT01139762 ·Status: COMPLETED ·Phase: PHASE3
-
Intermittent vs Daily Tamsulosin for LUTS/BPH
NCT07308002 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Tadalafil Plus Tamsulosin for Male LUTS and ED
NCT04383093 ·Status: COMPLETED
-
Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men
NCT00540124 ·Status: COMPLETED ·Phase: PHASE2
-
Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.
NCT00457457 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).
NCT02431754 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Study Between Rezum and Tamsulosin
NCT07169773 ·Status: COMPLETED ·Phase: NA
-
(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia
NCT05236634 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia
NCT04947631 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Tadalafil in Benign Prostatic Hyperplasia
NCT01183650 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction
NCT01967251 ·Status: WITHDRAWN ·Phase: PHASE2